Natural Products: Evidence for Neuroprotection to Be Exploited in Glaucoma
ReviewHumansOther animals
- Design
- Review
- Subjects
- Not stated in the abstract
- Dose used in the study
- Not stated in the abstract
- Duration
- Not stated in the abstract
- What was measured
- Why natural compounds and dietary supplements might protect retinal ganglion cells in glaucoma: neuroprotective mechanisms studied independently of eye pressure, in experimental and clinical models.
What the authors reported
The abstract reports no palmitoylethanolamide-specific findings or numbers. The authors frame glaucoma as progressive retinal ganglion cell loss with raised eye pressure as the main risk factor, and review natural compounds studied for IOP-independent neuroprotection.
Limits of this study
A narrative review, not a trial. The abstract does not describe search methods. One author (R.R.) received a grant from SOOFT Italia SpA, an eye-care company; the others declare no conflict.
Source
PubMed 33081127 · doi:10.3390/nu12103158
Entry checked against the abstract on PubMed on 2026-09-22. The dose shown is the dose the researchers used. It is not a recommendation. How to read this page.